Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 2Terminated 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 15Leukemia, Lymphocytic, Chronic, B-Cell 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Congenital Abnormalities 7Leukemia, Myelomonocytic, Acute 6Leukemia, Monocytic, Acute 6Leukemia, Erythroblastic, Acute 6Leukemia, Megakaryoblastic, Acute 5Lymphoma, Mantle-Cell 4Lymphoma, Follicular 4Waldenstrom Macroglobulinemia 3Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Prolymphocytic 3Blast Crisis 3Sezary Syndrome 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Immunoblastic Lymphadenopathy 2Hodgkin Disease 2Burkitt Lymphoma 2Thrombocytopenia 1

Interventions

Cyclophosphamide 64Peripheral Blood Stem Cell Transplantation 58fludarabine phosphate 55Busulfan 44Tacrolimus 39Methotrexate 38Cytarabine 37Filgrastim 34Mycophenolic Acid 33Cyclosporine 33Antilymphocyte Serum 32Whole-Body Irradiation 28Radiotherapy 25Methylprednisolone 22Imatinib Mesylate 22Etoposide 22Melphalan 18Cord Blood Stem Cell Transplantation 18Flow Cytometry 14Thiotepa 12Dasatinib 12Therapeutics 11sargramostim 10merphos 10fludarabine 10Sirolimus 10Granulocyte Colony-Stimulating Factor 10nilotinib 9Prednisone 9Carboplatin 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Blast Crisis × alvocidib × Other hematologic neoplasm × Clear all
NCT00101231 2013-06-04

Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia

National Cancer Institute (NCI)

Phase 1 Terminated
88 enrolled
LymphoidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00278330 2013-04-02

Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia

National Cancer Institute (NCI)

Phase 1 Completed
24 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00064285 2010-05-03

Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer

Virginia Commonwealth University

Phase 1 Completed
22 enrolled
LymphoidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡